Clinical Trial Update: A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension [Phase 4]

View source ↗

Summary

Phase IV study in subjects with neurogenic orthostatic hypotension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension Orthostatic

Snippet

Sponsor: Shire | Conditions: Hypotension, Orthostatic | Phase 4 | Status: TERMINATED